Volume 44, Issue 6, Pages (June 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 62, Issue 6, Pages (June 2015)
From: Perioperative Use of Dobutamine in Cardiac Surgery and Adverse Cardiac Outcome:Propensity-adjusted Analyses Anesthes. 2008;108(6): doi: /ALN.0b013e f.
Volume 63, Issue 1, Pages (July 2015)
Volume 357, Issue 9262, Pages (April 2001)
Volume 46, Issue 3, Pages (March 2007)
Volume 41, Issue 6, Pages (December 2004)
Inflammasomes in liver diseases
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Volume 42, Issue 6, Pages (June 2005)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Fibrogenic impact of high serum glucose in chro nic hepatitis C
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 128, Issue 2, Pages (February 2005)
Volume 44, Issue 4, Pages (April 2006)
Non-invasive diagnosis of non-alcoholic fatty liver disease
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 66, Issue 1, Pages 1-4 (January 2017)
Volume 69, Issue 1, Pages (July 2018)
Living donor liver transplantation: is the hype over?
Volume 42, Issue 2, Pages (February 2005)
Volume 41, Issue 3, Pages (September 2004)
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Liver fibrosis in overweight patients
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Volume 41, Issue 3, Pages (September 2004)
Volume 53, Issue 5, Pages (November 2010)
Hepatitis C core protein – The “core” of immune deception?
Volume 44, Issue 1, Pages (January 2006)
Volume 70, Issue 1, Pages (January 2019)
Triplex High-Resolution Melting Assay for the Simultaneous Assessment of IFNL3 rs , ABCB11 rs , and RNF7 rs Genotypes in Chronic.
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients  Dima L. Diab, Lisa Yerian, Philip.
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg 
Economics of chronic hepatitis B and hepatitis C
Analgesia nociception index for the assessment of pain in critically ill patients: a diagnostic accuracy study  G. Chanques, T. Tarri, A. Ride, A. Prades,
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease  Sylvie Naveau, Bruno Raynard, Vlad Ratziu, Annie Abella,
Correlation of FIBROSpect II With Histologic and Morphometric Evaluation of Liver Fibrosis in Chronic Hepatitis C  Keyur Patel, David R. Nelson, Don C.
A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis  Naim Alkhouri, Christine Carter–Kent,
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Non-invasive evaluation of liver fibrosis using transient elastography
Volume 64, Issue 6, Pages (June 2016)
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis
Volume 63, Issue 1, Pages (July 2015)
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 62, Issue 3, Pages (March 2015)
Evaluation of diagnostic tests
Ability of stroke volume variation measured by oesophageal Doppler monitoring to predict fluid responsiveness during surgery  P.-G. Guinot, B. de Broca,
Pathogenesis of cholestatic hepatitis C
The relationship between age and fat infiltration in liver and muscle
The Journal of Thoracic and Cardiovascular Surgery
Use of a high-fidelity simulator to develop testing of the technical performance of novice anaesthetists†   F.C. Forrest, M.A. Taylor, K. Postlethwaite,
MELD: the holy grail of organ allocation?
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Satisfaction With Activity and Participation and Its Relationships With Body Functions, Activities, or Environmental Factors in Stroke Patients  Édouard.
Volume 70, Issue 5, Pages (May 2019)
Presentation transcript:

Volume 44, Issue 6, Pages 1175-1185 (June 2006) The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato- hepatitis in patients with chronic alcoholic liver disease  Dominique Thabut, Sylvie Naveau, Frederic Charlotte, Julien Massard, Vlad Ratziu, Françoise Imbert-Bismut, Dominique Cazals-Hatem, Annie Abella, Djamila Messous, Fabienne Beuzen, Mona Munteanu, Julien Taieb, Richard Moreau, Didier Lebrec, Thierry Poynard  Journal of Hepatology  Volume 44, Issue 6, Pages 1175-1185 (June 2006) DOI: 10.1016/j.jhep.2006.02.010 Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Flow sheet of patients analyzed and included in the training and validation groups. Journal of Hepatology 2006 44, 1175-1185DOI: (10.1016/j.jhep.2006.02.010) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Diagnostic values of AshTest, Maddrey and AST/ALT ratio for the diagnosis of alcoholic hepatitis. Panel A: Box plots of AshTest, Maddrey and AST/ALT ratio according to severity of alcoholic hepatitis (n=225). A four grades scoring system was used to assess alcoholic hepatitis: 0 none, 1–2 mild, 3–4 moderate, 5–8 severe. This score combines elementary features (necrosis, polymorphonuclear infiltrate, Mallory bodies and ballooning). Notched box plots show the relationship between the biomarkers and grade of alcoholic hepatitis in the integrated database. The horizontal line inside each box represents the median and the width of each box the median±1.57 interquartile range/n to assess the 95% level of significance between group medians. Failure of the shaded boxes to overlap signifies statistical significance (P<0.05). The horizontal lines above and below each box encompass the interquartile range (from 25th to 75th percentile), and the vertical lines from the ends of the box encompass the adjacent values (upper: 75th percentile plus 1.5 times interquartile range, lower 25th percentile minus 1.5 times interquartile range). Panel B: ROC curves of AshTest (solid black line), Maddrey (grey line) and AST/ALT ratio (dotted line) for the diagnosis of alcoholic hepatitis (n=225). Journal of Hepatology 2006 44, 1175-1185DOI: (10.1016/j.jhep.2006.02.010) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Relationship between AshTest, Maddrey discriminant function and AST/ALT ratio according to each elementary features of alcoholic hepatitis. Polymorphonuclear infiltrate: 0, none; 1, moderate; 2, marked; necrosis: 0, none; 1, presence; Mallory bodies: 0, none; 1, moderate; 2, marked; ballooning: 0, none; 1, moderate; 2, marked. Journal of Hepatology 2006 44, 1175-1185DOI: (10.1016/j.jhep.2006.02.010) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions